Paper8175136
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
Heathcote EJ and 9 others. Hepatology, 1994. Cited by 373 papers, by iCite.
Cite this record
ConductScience Library. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Papers, record 8175136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8175136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Cirrhosis, Biliary | Major topic |
| Ursodeoxycholic Acid | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Alkaline Phosphatase | |
| Bilirubin | |
| Canada | |
| Cholestasis | |
| Cholesterol | |
| Double-Blind Method | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Immunoglobulin M | |
| Male | |
| Middle Aged | |
| Transaminases |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00006168 | Ursodiol-Methotrexate for Primary Biliary Cirrhosis | Background |
Source ClinicalTrials.gov
Cited by95
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 373 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41868880 | Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis. | Ann Gastroenterol | 2026 | https://conductscience.org/library/papers/41868880 | PubMed |
| 41251604 | Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database. | J Comp Eff Res | 2025 | https://conductscience.org/library/papers/41251604 | PubMed |
| 41103433 | Impact of the prognostic nutritional index on the recompensation of patients with decompensated primary biliary cholangitis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41103433 | PubMed |
| 40977287 | Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis. | Aliment Pharmacol Ther | 2026 | https://conductscience.org/library/papers/40977287 | PubMed |
| 40682413 | Pathogenesis, Non-Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases. | Liver Int | 2025 | https://conductscience.org/library/papers/40682413 | PubMed |
| 40672002 | Cost-Effectiveness of S-Adenosyl-L-Methionine for Intrahepatic Cholestasis in the United Arab Emirates. | Cureus | 2025 | https://conductscience.org/library/papers/40672002 | PubMed |
| 40646392 | The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine. | Clin Rev Allergy Immunol | 2025 | https://conductscience.org/library/papers/40646392 | PubMed |
| 40568038 | Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology. | World J Gastrointest Pathophysiol | 2025 | https://conductscience.org/library/papers/40568038 | PubMed |
| 40545045 | The history and future of bile acid therapies. | J Hepatol | 2025 | https://conductscience.org/library/papers/40545045 | PubMed |
| 40115760 | Bile acid therapy for primary biliary cholangitis: Pathogenetic validation. | World J Exp Med | 2025 | https://conductscience.org/library/papers/40115760 | PubMed |
| 39728045 | Up-to-Date Snapshot of Current and Emerging Medical Therapies in Primary Biliary Cholangitis. | J Pers Med | 2024 | https://conductscience.org/library/papers/39728045 | PubMed |
| 38178006 | Pharmacotherapy for primary biliary cholangitis: an assessment of medication candidacy and rates of treatment. | BMC Gastroenterol | 2024 | https://conductscience.org/library/papers/38178006 | PubMed |
| 36388729 | Management of biliary stones in bariatric surgery. | Ther Adv Gastrointest Endosc | 2022 | https://conductscience.org/library/papers/36388729 | PubMed |
| 36339545 | Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36339545 | PubMed |
| 34007800 | Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis. | J Clin Transl Hepatol | 2021 | https://conductscience.org/library/papers/34007800 | PubMed |
| 32861449 | Recent developments in diagnostics and treatment of neonatal cholestasis. | Semin Pediatr Surg | 2020 | https://conductscience.org/library/papers/32861449 | PubMed |
| 32039371 | New treatments/targets for primary biliary cholangitis. | JHEP Rep | 2019 | https://conductscience.org/library/papers/32039371 | PubMed |
| 31762074 | Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. | Aliment Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31762074 | PubMed |
| 30903105 | Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics. | Nat Rev Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/30903105 | PubMed |
| 30862662 | Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells. | EMBO Mol Med | 2019 | https://conductscience.org/library/papers/30862662 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8175136
GET https://conductscience.org/api/papers/v1/8175136/cited_by?page=2